Literature DB >> 5831048

The nature of the metabolites of acetohexamide in the rat and in the human.

R E McMahon, F J Marshall, H W Culp.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5831048

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

Review 1.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 2.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 3.  Clinical pharmacokinetics of sulphonylurea hypoglycaemic drugs.

Authors:  L Balant
Journal:  Clin Pharmacokinet       Date:  1981 May-Jun       Impact factor: 6.447

4.  Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.

Authors:  R J Lewis; W F Trager; K K Chan; A Breckenridge; M Orme; M Roland; W Schary
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

5.  Highly potent and stereoselective effects of the benzoic acid derivative AZ-DF 265 on pancreatic beta-cells.

Authors:  M G Garrino; J C Henquin
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

6.  Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent.

Authors:  Koki Fujimori; Mitsuru Ishikawa; Asako Otomo; Naoki Atsuta; Ryoichi Nakamura; Tetsuya Akiyama; Shinji Hadano; Masashi Aoki; Hideyuki Saya; Gen Sobue; Hideyuki Okano
Journal:  Nat Med       Date:  2018-08-20       Impact factor: 53.440

Review 7.  Metabolic-Hydroxy and Carboxy Functionalization of Alkyl Moieties in Drug Molecules: Prediction of Structure Influence and Pharmacologic Activity.

Authors:  Babiker M El-Haj; Samrein B M Ahmed
Journal:  Molecules       Date:  2020-04-22       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.